AstraZeneca sells U.S. drug rights to Perrigo for $380 mln
November 23, 2015 at 02:25 AM EST
Nov 23 (Reuters) - AstraZeneca said on Monday it had finalised plans to divest its Crohn's disease drug Entocort by selling U.S. rights to the medicine to Perrigo for $380 million.
